SOLV Stock Analysis: Buy, Sell, or Hold?
SOLV - Solventum Corporation
$74.42
0.01 (0.01%)
▲
5d:
+3.87%
30d:
+7.7%
90d:
-2.01%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$104.27
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$64.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $74.42, which is considered extended relative to its 30-day fair value range of $65.89 to $72.17. The stock's valuation (Forward PE: 10.6) is in line with its historical norms (11.2). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SOLV is in a strong downtrend. The price is approaching resistance at $75.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SOLV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOLV is in a strong downtrend. The price is approaching resistance at $75.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SOLV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$65.89 -
$72.17
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($81.08)
Trading Range Analysis
30-Day Trading Range
$65.89 -
$72.17
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$66.26
Resistance Level
$75.91
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.57
Wall Street Target
$81.08
(+9.0%)
Revenue Growth (YoY)
-3.0%
Earnings Growth (YoY)
-91.0%
Profit Margin
17.3%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
10.6 vs 11.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$73.08
(-2%)
2-Year Target
$71.76
(-4%)
3-Year Target
$70.47
(-5%)
3-Yr Target (if PE normalizes)
(PE: 11→11)
$74.69
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 7.5%)
$192.80
(+159%)
Base:
(SPY PE: 10.6, Growth: 7.5%)
$92.44
(+24%)
Bear:
(PE: 9.0, Growth: 7.5%)
$78.58
(+6%)
📈
Valuation based on Current Earnings
Trailing PE: 9.11 | Current EPS (TTM): $8.17
Bull Case
$70.55
(-5%)
Analyst growth -13.8%, PE expands to 10.0
Base Case
$64.14
(-14%)
Market implied -13.8%, PE stable at 9.1
Bear Case
$50.60
(-32%)
Severe decline -20.0%, PE contracts to 7.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.6 to 11.2
Stabilization Target:
$78.87
(+6.0%)
PE Expansion Potential:
+6.0%
Share & Embed Analysis
Last updated: May 14, 2026 8:16 PM ET
Data refreshes hourly during market hours. Next update: 9:16 PM
Data refreshes hourly during market hours. Next update: 9:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Amy Mcbride Wendell
BUY
1475 shares
2026-03-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$180 | 52 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
